Chenghui Luo
Overview
Explore the profile of Chenghui Luo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
6
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li H, Yang L, Luo C, Liu L, Li C, Wang J, et al.
Environ Pollut
. 2025 Jan;
367:125655.
PMID: 39778733
Soil microplastics (MPs) are a substantial threat to soil health, particularly by disrupting soil aggregation. Additionally, MPs undergo aging processes in the soil, which may significantly alter their long-term impacts...
2.
Jiang Y, Huang L, Liao H, Luo C, Zhang C, Mao W
Disaster Med Public Health Prep
. 2024 May;
18:e85.
PMID: 38699831
Objective: To investigate the rate of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody among unvaccinated voluntary blood donors in Chongqing, and to provide evidence for epidemic surveillance. Methods: A...
3.
Li Y, Guo S, Wu X, Wan J, Guan Y, Luo C, et al.
Bioorg Chem
. 2024 May;
147:107405.
PMID: 38696843
The prolonged intravitreal administration of anti-vascular endothelial growth factor (VEGF) drugs is prone to inducing aberrant retinal vascular development and causing damage to retinal neurons. Hence, we have taken an...
4.
Pei Y, Xiao Z, Wei S, Peng M, Luo C, Wang D
J Inflamm Res
. 2022 Nov;
15:6343-6355.
PMID: 36424919
Background: In tropical and subtropical areas, allergens from the dust mite species are common causes of allergic rhinitis and asthma. has two main allergens: Blo t 5 and Blo t...
5.
Sun Y, Wang B, Pei J, Luo Y, Yuan N, Xiao Z, et al.
Br J Pharmacol
. 2022 Feb;
179(14):3740-3753.
PMID: 35135035
Background And Purpose: Hirudin variants are the most powerful thrombin inhibitors discovered to date, with a lower risk of bleeding than heparin. For anticoagulation, the C-termini of hirudin variants bind...